Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLendinvest Regulatory News (LINV)

Share Price Information for Lendinvest (LINV)

Share Price is delayed by 15 minutes
Get Live Data
24.50    -0.70 (-2.78%)
Bid:
24.00
Ask:
25.00
Spread: 1.00 (4.167%)
Market Cap: £34.70m
LINV Live PriceLast checked at - London Stock Exchange

Intraday Lendinvest Share Chart

Board Changes

4 Jun 2024 09:58

RNS Number : 0420R
Lendinvest PLC
04 June 2024
 

LEI: 213800NWMK3O4UWP9N91 

4 June 2024

 

LendInvest plc

Board Changes

 

LendInvest plc (AIM: LINV) ("LendInvest" or the "Company"), the UK's leading platform for mortgages, today announces that it has been formally notified by Penny Judd of her intention to step down from her position as Independent Non-Executive Director of the Company and Chair of the Audit & Risk Committee with effect from the publication of the Company's annual results in July 2024 in order to focus on her other directorships and commitments.

 

Maeve Byrne has been appointed to succeed Penny Judd as an Independent Non-Executive Director of the Company and Chair of the Audit & Risk Committee. Maeve will also be a member of the Company's Nomination and Remuneration Committees. Maeve is an accomplished financial services professional who brings over 30 years of experience to her new role. She has held key leadership positions at respected institutions like RBS and KPMG and currently serves as a Non-Executive Director and Audit Committee Chair at Alpha FMC. Maeve's expertise in governance and financial oversight will be instrumental as she steps into the roles of Independent Non-Executive Director and Chair of the Audit & Risk Committee, contributing her insight to the Company's strategic goals. Maeve's appointment to the Board will be effective immediately to allow sufficient time for an orderly transition from Penny.

 

The Company further announces that Nina Spencer, Independent Non-Executive Director, and Dale Murray, Independent Non-Executive Director, have also notified their intention to not seek re-election by shareholders at the Company's Annual General Meeting (AGM) in September 2024 in order to devote more time to their business engagements and other directorships.

The Board remains otherwise unchanged. Following the Company's AGM, the Board will constitute three Non-Executive Directors, two of whom are considered independent, and two Executive Directors. The Board believes this to be an appropriate size and balance of skills to steer the Company on its continued path towards returning the Company to profitability, but will keep the size and composition of the Board under ongoing review.

 

The Board would like to take this opportunity to express its sincere gratitude to Penny, Nina and Dale for their valuable contributions to the Company during their tenure of directorship.

 

Rod Lockhart, Chief Executive Officer at LendInvest said: "I want to personally thank Penny, Nina, and Dale for their dedication and invaluable contributions to LendInvest during this crucial phase of change and growth over our first three years as a public company. Their collective experience and support have been instrumental in shaping our progress, and we wish them every success in their future endeavours.

 

"We are delighted to welcome Maeve to the LendInvest Board. Maeve brings a wealth of experience and deep insight that will be of significant value to the company as we continue on our path back to profitability."

 

Maeve Byrne, Independent Non-Executive Director added: "I am delighted to join the LendInvest Board at such an important time for the Company. I'm impressed by the management team and eager to bring my experience to help navigate the evolving financial landscape, guide LendInvest toward continued success and help support the business in the next stage of its growth journey."

 

Following the above changes, Panmure Gordon (UK) Limited will serve as Nominated Adviser and sole corporate broker to the Company going forward with immediate effect.

 

Further information

 

Maeve Ann Byrne, aged 57, is, or has been, a director or partner of the following companies or partnerships during the past five years:

 

Current directorships and partnerships

Past directorships and partnerships (past 5 years)

Lisnagroagh Ltd

None.

Alpha Financial Markets Consulting Plc

 

Maeve Byrne does not hold any legal or beneficial direct or indirect interest in the securities of the Company.

 

There is no further information required to be disclosed in respect of the above appointment pursuant to Rule 17 or Schedule 2 (g) of the AIM Rules for Companies.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

Enquiries:

LendInvest via Teneo +44 (0)20 7353 4200Rod Lockhart, Chief Executive Officer

Hugo Davies, Chief Capital Officer & Interim CFOLeigh Rimmer, Director of Communications investorrelations@lendinvest.com

 

Panmure Gordon (NOMAD and Joint Broker) +44 (0)20 7886 2500Atholl TweedieDavid Watkins 

Teneo (Financial PR) +44 (0)20 7353 4200Tom MurrayEd CropleyOlivia Lucas

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUMAQUPCURC
Date   Source Headline
9th Feb 20245:23 pmRNSBlock Listing Six Monthly Return
26th Jan 202410:17 amRNSDirector/PDMR Notification
24th Jan 20247:00 amRNSPDMR dealing
5th Jan 20247:00 amRNSSale of residual economic interest in RMBS
19th Dec 20237:00 amRNSInterim Financial Results
30th Nov 20237:00 amRNSAnnouncement of Securitisation Settlement
22nd Nov 20234:42 pmRNSAnnouncement of Securitisation Transaction
4th Oct 20237:00 amRNSNotification of transactions by PCA with PDMR
28th Sep 202310:54 amRNSPublication of Final Terms
28th Sep 20238:19 amRNSFinal Terms Confirmation
22nd Sep 202310:26 amRNSIssue of shares to EBT and Total Voting Rights
18th Sep 202312:05 pmRNSResults of AGM
13th Sep 20231:23 pmRNSLaunch of 11.5% Bonds due 2026 and Exchange Offer
12th Sep 20231:42 pmRNSPublication of Base Prospectus
8th Sep 20239:57 amRNSConclusion of IT security event
5th Sep 202310:30 amRNSTrading update
4th Sep 202310:00 amRNSRoadshow announcement
25th Aug 20237:00 amRNSNotice of data breach
11th Aug 20238:59 amRNSBlock listing Interim Review
10th Aug 20231:55 pmRNSHolding(s) in Company
10th Aug 20231:47 pmRNSHolding(s) in Company
7th Aug 20234:28 pmRNSHolding(s) in Company
7th Aug 20234:26 pmRNSDirector/PDMR Notification
18th Jul 20237:00 amRNSLendInvest plc Full Year Financial Results FY23
3rd Jul 20237:00 amRNSAnnouncement of £500 million funding partnership
30th May 20237:00 amRNSLendInvest sells Buy-to-Let mortgage portfolio
5th May 202312:07 pmRNSPDMR Exercise of Share Options
5th May 202311:53 amRNSDirectorate Change
19th Apr 20233:22 pmRNSSale of residual economic interest in RMBS
13th Apr 20237:00 amRNSTrading Update
22nd Mar 202311:40 amRNSIssue of Shares to EBT and Total Voting Rights
1st Mar 20234:47 pmRNSSale of residual economic interest in RMBS
13th Feb 20237:00 amRNSBlock Listing Six Monthly Return
3rd Feb 20234:24 pmRNSDirector/PDMR Notification
17th Jan 20237:00 amRNSLendInvest secures funding from Lloyds Bank
19th Dec 20224:18 pmRNSNew £100 million financial partnership
19th Dec 20227:00 amRNSDirectorate Change
30th Nov 20227:00 amRNSInterim Financial Results
14th Oct 202210:41 amRNSDirector/PDMR Shareholding
11th Oct 202210:09 amRNSDirector/PDMR Shareholding
10th Oct 20227:00 amRNSTrading Update
8th Sep 20224:02 pmRNSResult of AGM
16th Aug 202210:56 amRNSPDMR Exercise of Share Options
12th Aug 20221:29 pmRNSSale of residual economic interest in RMBS
12th Aug 20227:00 amRNSBlock Listing Six Monthly Return
5th Aug 20227:55 amRNSNotice of Annual General Meeting
29th Jul 20223:14 pmRNSHolding(s) in Company
29th Jul 20223:12 pmRNSHolding(s) in Company
12th Jul 202212:38 pmRNSPublication of Base Prospectus
11th Jul 20224:48 pmRNSUpdate on EBT Purchase and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.